KR900006309A - 신규 2-카르보닐 치환 n, n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물 - Google Patents

신규 2-카르보닐 치환 n, n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물 Download PDF

Info

Publication number
KR900006309A
KR900006309A KR1019890014506A KR890014506A KR900006309A KR 900006309 A KR900006309 A KR 900006309A KR 1019890014506 A KR1019890014506 A KR 1019890014506A KR 890014506 A KR890014506 A KR 890014506A KR 900006309 A KR900006309 A KR 900006309A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
piperazine
compound
administration
Prior art date
Application number
KR1019890014506A
Other languages
English (en)
Other versions
KR970004912B1 (ko
Inventor
피로스키 에뒤아르도
디브 죠르쥐
고드프르와 장-자끄
에이망 프랑스와즈
브라께 삐에르
Original Assignee
게라르 보푸르
소시에떼 드 꽁세이으 드 르세르세에 다쁠리까시옹 시앙띠피끄(에스.세.에흐.아.에스)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게라르 보푸르, 소시에떼 드 꽁세이으 드 르세르세에 다쁠리까시옹 시앙띠피끄(에스.세.에흐.아.에스) filed Critical 게라르 보푸르
Publication of KR900006309A publication Critical patent/KR900006309A/ko
Application granted granted Critical
Publication of KR970004912B1 publication Critical patent/KR970004912B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

신규 2-카르보닐 치환 N,N'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기 일반식 I을 갖는 피페라진 유도체.
    식 중, Y는을 나타내고, Z는 치환제 OA 또는 치환제를 나타내며, 여기에서 A는 1 내지 12개의 탄소 원자를 갖는 직쇄 또는 분자쇄 알킬기, 5 내지 10개의 탄소 원자를 갖는 시클로알킬기 또는 다음 구조식의 기를 나타내고,
    (여기에서, n은 0 또는 1 내지 5의 정수이고, R1,R2,R3,R4및 R5는 각기 독립적으로 수소, 염소 또는 브롬 원자, 트리플루오로메틸기, 트리플루오로메톡시기, 트리플루오로 티오기, 메틸기 또는 메톡시기임), A1및 A2는 수소 원자를 나타내거나 또는 상기 정의된 A와 동일하거나, 또는 A1과 A2가 함께 5 내지 10개의 탄소 원자를 갖는 시클로 알킬기를 형성한다.
  2. 하기 일반식 Ⅱ의 화합물을 트리에틸아민 존재하에 반양성자성 용매(예, 벤젠 또는 톨루엔)에서 등몰량의 N,N'-디벤질에틸렌디아민과 80℃에서 반응시키고, 이와 같이하여 얻은 하기 일반식 Ⅲ의 삼치환 피페라진을 알코올 용매에서 Pd/목탄 존재하에 40℃, 가압 하에 수소참가분해를 시킨 다음, 이와 같이 하여 생성된 하기 일반식 Ⅳ의 대응하는 일치환 피페라진을 트리에틸아민 존재하에 실온에서 벤젠중의 3,4,5-트리메톡시벤조일클로라이드로 처리하는 것으로 되는 제1항의 화합물의 제조방법.
    (식중, Z은 상기 정의된 바와같음)
  3. 단위 투여량 당 경우 투여에 대해 50 내지 100mg, 정맥내 투여에 대해 5 내지 100mg의 제1항에 의한 화합물 1종 이상과, 선택된 투여 경로에 적합한 부형제로 되는 치료 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890014506A 1988-10-11 1989-10-10 신규 2-카르보닐 치환 n,n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물. KR970004912B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888823775A GB8823775D0 (en) 1988-10-11 1988-10-11 New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823775.5 1988-10-11

Publications (2)

Publication Number Publication Date
KR900006309A true KR900006309A (ko) 1990-05-07
KR970004912B1 KR970004912B1 (ko) 1997-04-08

Family

ID=10644988

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014506A KR970004912B1 (ko) 1988-10-11 1989-10-10 신규 2-카르보닐 치환 n,n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물.

Country Status (33)

Country Link
US (1) US4923870A (ko)
JP (1) JPH0635452B2 (ko)
KR (1) KR970004912B1 (ko)
AR (1) AR245110A1 (ko)
AT (1) AT395423B (ko)
AU (1) AU618220B2 (ko)
BE (1) BE1003519A3 (ko)
CA (1) CA1320958C (ko)
CH (1) CH679859A5 (ko)
DE (1) DE3933881C2 (ko)
DK (1) DK500389A (ko)
DZ (1) DZ1365A1 (ko)
ES (1) ES2018403A6 (ko)
FI (1) FI96854C (ko)
FR (2) FR2637593B1 (ko)
GB (2) GB8823775D0 (ko)
GR (1) GR1000343B (ko)
HK (1) HK47592A (ko)
IE (1) IE62011B1 (ko)
IN (1) IN173325B (ko)
IT (1) IT1237088B (ko)
LU (1) LU87604A1 (ko)
MA (1) MA21652A1 (ko)
MY (1) MY106235A (ko)
NL (1) NL8902520A (ko)
NO (1) NO176180C (ko)
NZ (1) NZ230927A (ko)
OA (1) OA09139A (ko)
PT (1) PT91941B (ko)
SE (1) SE505239C2 (ko)
SG (1) SG41292G (ko)
TN (1) TNSN89110A1 (ko)
ZA (1) ZA897554B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB8908587D0 (en) * 1989-04-15 1989-06-01 Scras Societe De Conseils De R New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
US5292726A (en) * 1991-05-22 1994-03-08 Merck & Co., Inc. N,N-diacylpiperazines
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5348955A (en) * 1993-06-22 1994-09-20 Merck & Co., Inc. N,N-diacylpiperazines
FR2780649B1 (fr) 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186993A (en) * 1962-06-07 1965-06-01 Ethyl Corp alpha, alpha'-(1, 4-piperazinediyl) bis (3, 5-dialkyl-4-hydroxythiobenzaldehyde) compounds
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
DE2423847A1 (de) * 1973-05-28 1975-01-02 Ciba Geigy Ag Neue sulfamoylbenzoesaeureamide
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
DE3636278A1 (de) * 1986-10-24 1988-05-05 Hoechst Ag Herbizide mittel auf der basis von cyclischen (alpha)-iminocarbon-saeureaniliden sowie neue (alpha)-iminocarbonsaeureanilide und verfahren zu ihrer herstellung
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
FR2637500A1 (fr) 1990-04-13
LU87604A1 (fr) 1990-02-07
SE8903312L (sv) 1990-04-12
CH679859A5 (ko) 1992-04-30
JPH02223565A (ja) 1990-09-05
AU4268889A (en) 1990-04-26
FI96854C (fi) 1996-09-10
IN173325B (ko) 1994-04-02
IT8921992A0 (it) 1989-10-11
ATA234689A (de) 1992-05-15
DZ1365A1 (fr) 2004-09-13
OA09139A (fr) 1991-10-31
GB2223753A (en) 1990-04-18
AT395423B (de) 1992-12-28
GR1000343B (el) 1992-06-25
PT91941B (pt) 1995-05-31
BE1003519A3 (fr) 1992-04-14
MY106235A (en) 1995-04-29
SE8903312D0 (sv) 1989-10-09
GB8823775D0 (en) 1988-11-16
SG41292G (en) 1992-06-12
FR2637500B1 (fr) 1992-06-05
IE893258L (en) 1990-04-11
IT8921992A1 (it) 1991-04-11
MA21652A1 (fr) 1990-07-01
KR970004912B1 (ko) 1997-04-08
DE3933881A1 (de) 1990-04-12
SE505239C2 (sv) 1997-07-21
IE62011B1 (en) 1994-12-14
PT91941A (pt) 1990-04-30
DE3933881C2 (de) 1994-06-30
NO176180B (no) 1994-11-07
FR2637593B1 (fr) 1992-06-05
NO176180C (no) 1995-02-15
GR890100647A (en) 1990-11-29
NZ230927A (en) 1991-01-29
HK47592A (en) 1992-07-10
JPH0635452B2 (ja) 1994-05-11
DK500389D0 (da) 1989-10-10
FI894812A0 (fi) 1989-10-11
FR2637593A1 (fr) 1990-04-13
ES2018403A6 (es) 1991-04-01
FI894812A (fi) 1990-04-12
GB8922870D0 (en) 1989-11-29
NO894038L (no) 1990-04-17
DK500389A (da) 1990-04-12
US4923870A (en) 1990-05-08
ZA897554B (en) 1990-07-25
AR245110A1 (es) 1993-12-30
IT1237088B (it) 1993-05-18
GB2223753B (en) 1992-01-02
NL8902520A (nl) 1990-05-01
TNSN89110A1 (fr) 1991-02-04
NO894038D0 (no) 1989-10-10
FI96854B (fi) 1996-05-31
CA1320958C (en) 1993-08-03
AU618220B2 (en) 1991-12-12

Similar Documents

Publication Publication Date Title
FI880510A0 (fi) Menetelmä lääkeaineena käyttökelpoisen tiatsolidinonin johdannaisen valmistamiseksi
NL300034I2 (nl) Gesubstitueerde thiahzolidinedionderivaten.
RU95108329A (ru) Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция
JPS55167263A (en) 33aminoo1*22propanediol derivative* its manufacture* drug blend containing it and its use
AU6129890A (en) Novel compounds
KR850004463A (ko) 디히드로피리딘 유도체의 제조방법
AU6128590A (en) Novel compounds
KR880013888A (ko) 신규 디티오아세탈 화합물, 그의 제조방법 및 이 화합물로 되는 제약 조성물
RU95108759A (ru) Фармацевтические соединения
KR920021547A (ko) 아졸 유도체
DK0488513T3 (da) Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen
KR900014396A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR900006309A (ko) 신규 2-카르보닐 치환 n, n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
KR900009640A (ko) 벤족 사제핀 유도체
FR2591599B1 (fr) Nouvelles anthracyclines et medicaments les contenant
ATE34739T1 (de) Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
KR890005078A (ko) 벤조푸란 유도체 및 이의 제조방법
KR840005105A (ko) 의약용 피리다지논류 유도체의 제조방법
KR900006310A (ko) 신규 2-메톡시카르보닐 치환, n,n'-디(트리메톡시벤조일) 피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
ATE95180T1 (de) Berbanderivate und ihre herstellung und pharmazeutische zubereitung.
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee